Back to Trades
Sell4
CHEVRON CORP
CVX
Total Value
$21.8M
Net $8.0M sold
Sales
$8.0M
2 transactions
Company Information
- Company Name
- CHEVRON CORP
- Ticker Symbol
- CVX
- CIK
- 0000093410
Insider Information
- Name
- NELSON MARK A
- Role
- Vice Chairman
- Location
- HOUSTON, TX
Officer
Filing Details
- Filing Date
- Feb 3, 2026
- Transaction Date
- Jan 31, 2026
- Accession Number
- 0000093410-26-000042
- Form Type
- 4
- Net Trading Amount
- -$8.0M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 31, 2026 | Common Stock | 13,347 | — | Exercise | — |
| Jan 31, 2026 | Common Stock | 13,347 | $176.90 | Disposition | $2.4M |
| Jan 31, 2026 | Common Stock | 2,912 | — | Exercise | — |
| Jan 31, 2026 | Common Stock | 1,265 | $176.90 | Tax Withholding | $223.8K |
| Feb 2, 2026 | Common Stock | 18,100 | $117.24 | Exercise | $2.1M |
| Feb 2, 2026 | Common Stock | 18,100 | $174.28 | Sale | $3.2M |
| Feb 2, 2026 | Common Stock | 27,700 | $125.35 | Exercise | $3.5M |
| Feb 2, 2026 | Common Stock | 27,700 | $174.09 | Sale | $4.8M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jan 31, 2026 | Derivative | 13,347 | — | Exercise | — |
| Jan 31, 2026 | Derivative | 2,912 | — | Exercise | — |
| Feb 1, 2026 | Derivative | 24,120 | — | Grant/Award | — |
| Feb 2, 2026 | Derivative | 18,100 | $117.24 | Exercise | $2.1M |
| Feb 2, 2026 | Derivative | 27,700 | $125.35 | Exercise | $3.5M |
Footnotes
- (F1)Each restricted stock unit is the economic equivalent of one share of Chevron common stock.
- (F2)This transaction was executed in multiple trades at prices ranging from $174.22 to $174.40. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.
- (F3)This transaction was executed in multiple trades at prices ranging from $173.88 to $174.30. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.
- (F4)Between December 18, 2025 and February 2, 2026, the reporting person acquired 18 shares of Chevron common stock under the Chevron Employee Savings Investment Plan, a 401(k) Plan.
- (F5)This number includes dividend equivalents (1,583 shares).
- (F6)Restricted stock units accrue dividend equivalents in the form of additional restricted stock units. The restricted stock units are payable in cash and vested on January 31, 2026.
- (F7)This number includes dividend equivalents (127 shares).
- (F8)Restricted stock units granted on January 25, 2023 under the Chevron Corporation 2022 Long-Term Incentive Plan. Restricted stock units accrue dividend equivalents in the form of additional restricted stock units. One-third of the shares subject to the award vested on January 31, 2024, January 31, 2025 and January 31, 2026, respectively and settled in shares of Chevron common stock on the date of vesting. Shares issued upon vesting are subject to a two-year post-vesting holding period, which is removed upon termination of employment.
- (F9)Restricted stock units granted under the Chevron Corporation 2022 Long-Term Incentive Plan. Restricted stock units accrue dividend equivalents in the form of additional restricted stock units. One-third of the shares subject to this award will vest on February 1, 2027, February 1, 2028 and February 1, 2029, respectively, and will settle in shares of Chevron common stock on the date of vesting. Shares issued upon vesting are subject to a two-year post-vesting holding period, which is removed upon termination of employment.
- (F10)Option granted 1/25/2017. One-third of the shares subject to the option vested on January 31, 2018, January 31, 2019 and January 31, 2020, respectively.
- (F11)Option granted 1/31/2018. One-third of the shares subject to the option vested on January 31, 2019, January 31, 2020 and January 31, 2021, respectively.